2024 APASL|廖家杰教授:HIMALAYA研究4年OS和安全性结果重磅公布,3篇oral助力不可切除HCC患者更多获益 前言 3月27日-31日,第33届亚太肝病研究学会年会(Asian-Pacific Association for the Study of the Liver,APASL)在日本京都隆重召开...
Warrior Met Coal, Inc. 2024 Q4 - Results - Earnings Call Presentation Press Releases See All Press Releases » HCC Income Statement HCC Balance Sheet HCC Cash Flow Statement HCC Long Term Solvency Total Debt / Equity (MRQ) 8.28% Total Debt / Capital (MRQ) ...
近期,2024年欧洲肿瘤内科学会(ESMO)年会于9月13日-17日在西班牙巴塞罗那盛大召开,为各国学者提供交流的专业平台,推动肿瘤事业的有力发展。本次大会上,消化道肿瘤领域有多项临床研究均取得了重大突破,覆盖肝癌、胆道癌、胃癌等多个癌种,涉及度...
demonstrating improved progression-free survival (PFS) in pts with locoregional HCC treated with D + B + TACE versus placebos (PBO) + TACE (stratified Cox proportional hazards hazard ratio [HR], 0.77; 95% confidence interval [CI], 0.61–0.98 [Lencioni R, et al.J Clin Oncol2024;42(suppl...
Methods: HCC patients with MVI who had Child-Turcotte-Pugh A-B7 were included between Q4/2002 and Q2/2022. Localization of the tumour thrombus and changes at 3–6 months were evaluated by two radiologists. Univariable and multivariable logistic/Cox regression analyses included time-dependent ...
EMERALD-1研究的成功是一个重要的里程碑,它标志着局部晚期肝细胞癌(HCC)治疗的重大进展。这项研究验证了TACE(经动脉化疗栓塞治疗)联合免疫治疗(度伐利尤单抗)±抗VEGF治疗(贝伐珠单抗)的有效性和安全性,为这一患者群体提供了新的治疗选项。 在过去,TACE已经作为符合栓塞标准的HCC的标准治疗方案近20年,但是患者的中...
Q2: Upper right quadrant (UR) represented late apoptotic cells; Q3: Lower left quadrant (LL) represented viable (live) cells; Q4: Lower right quadrant (LR) represented early apoptotic cells. The apoptotic rate was analyzed by assessing the percentages of cells in the Q2 and Q4 quadrants [67...
本周,纽约商品交易所主力黄金期货价格在仅有的四个交易日内实现四连涨,并连续两天刷新收盘历史新高。截至28日收盘,纽约商品交易所主力黄金期价收于每盎司2238.40美元。整个3月份,纽约黄金期价累计上涨近8%,创2022年11月以来最大月度涨幅。
Pts whose tumors had lower CTNNB1 expression had significantly improved OS, 17.9 vs 12.4 months, Q1 vs Q4, HR 0.72, CI: 0.58-0.89 p=0.002. This association remained significant in patients who received first-line IO (Q1 vs Q4: OS 16.7 vs 10.6 mo, HR 0.54, CI: 0.32-0.94, p=0.025)...
2024 APASL|廖家杰教授:HIMALAYA研究4年OS和安全性结果重磅公布,3篇oral助力不可切除HCC患者更多获益 前言 3月27日-31日,第33届亚太肝病研究学会年会(Asian-Pacific Association for the Study of the Liver,APASL)在日本京都隆重召开。在为期5天的学术盛宴中,亚太地区及世界各地的专家学者通过线上线下结合的形式,...